Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Cancers|April 14, 2025
Evaluating the Potential of PSMA Targeting in CNS Tumors: Insights from Large-Scale Transcriptome ProfilingAdam Kraya, Komal Rathi, Run Jin, et al.NPJ Precision Oncology|June 19, 2023
Radiomics for characterization of the glioma immune microenvironmentNastaran Khalili, Anahita Fathi Kazerooni, Ariana Familiar, et al.The Journal of Investigative Dermatology|February 12, 2018
Uncommon Filaggrin Variants Are Associated with Persistent Atopic Dermatitis in African AmericansDavid J Margolis, Nandita Mitra, Heather Gochnauer, et al.AJNR. American Journal of Neuroradiology|July 29, 2026
Uncertainty-Aware Risk Stratification in Pediatric Low-Grade Glioma Using Multimodal DataFadel Batal, Bhavyasri Vunnava, Adam Kraya, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 19, 2026
Metabolic Imaging and Molecular Signatures Reveal Metabolic Phenotypes in Recurrent GlioblastomaElizabeth J Li, Adam Kraya, Pedro Costa-Pinheiro, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 18, 2023
Everolimus for Children With Recurrent or Progressive Low-Grade Glioma: Results From the Phase II PNOC001 TrialDaphne A Haas-Kogan, Mariam S Aboian, Jane E Minturn, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 19, 2022
Upfront Biology-Guided Therapy in Diffuse Intrinsic Pontine Glioma: Therapeutic, Molecular, and Biomarker Outcomes from PNOC003Cassie Kline, Payal Jain, Lindsay Kilburn, et al.AJNR. American Journal of Neuroradiology|February 14, 2025
Imaging Clusters of Pediatric Low-Grade Glioma are Associated with Distinct Molecular CharacteristicsAnahita Fathi Kazerooni, Adam Kraya, Komal S Rathi, et al.Nature Communications|January 2, 2025
Multiparametric MRI along with machine learning predicts prognosis and treatment response in pediatric low-grade gliomaAnahita Fathi Kazerooni, Adam Kraya, Komal S Rathi, et al.Nature Medicine|May 4, 2021
Evolution of delayed resistance to immunotherapy in a melanoma responderDavid Liu, Jia-Ren Lin, Emily J Robitschek, et al.Pageof 1